Local health departments have not recommended additional vaccination beyond current guidelines. Texas health officials urge immunization to protect against and prevent the spread of measles. ARC has received additional vaccines for children and adults to keep the community protected. Read our measles vaccination guidelines.
Visit the DSHS website to track the current outbreak in Texas.
If you have received a letter from UnitedHealthcare (UHC) stating that any of the providers listed below are out-of-network, please be informed that refers to their former practice. The following physicians and APC remain in-network at ARC, and you may continue seeing them without any changes to your coverage:
Ongoing clinical studies are studies that are currently in progress and no longer enrolling new participants. Visit our Enrolling Studies page for a full list of clinical studies you may be eligible to participate in.
A phase III trial to assess the efficacy, safety, and tolerability of zibotentan combined with dapagliflozin, compared to dapagliflozin alone, in participants with chronic kidney disease and high proteinuria.